Reflections on the Potential and Risks of AI for Scientific Article Writing after the AI Endorsement by Some Scientific Publishers: Focusing on Scopus AI.
Jose De Leon, Santiago De Leon-Martinez, Antonio Artés-Rodríguez, Enrique Baca-García, Carlos De Las Cuevas
{"title":"Reflections on the Potential and Risks of AI for Scientific Article Writing after the AI Endorsement by Some Scientific Publishers: Focusing on Scopus AI.","authors":"Jose De Leon, Santiago De Leon-Martinez, Antonio Artés-Rodríguez, Enrique Baca-García, Carlos De Las Cuevas","doi":"10.62641/aep.v53i2.1849","DOIUrl":null,"url":null,"abstract":"<p><p>The introduction of ChatGPT3 in 2023 disrupted the field of artificial intelligence (AI). ChatGPT uses large language models (LLMs) but has no access to copyrighted material including scientific articles and books. This review is limited by the lack of access to: (1) prior peer-reviewed articles and (2) proprietary information owned by the companies. Despite these limitations, the article reviews the use of LLMs in the publishing of scientific articles. The first use was plagiarism software. The second use by the American Psychological Association and Elsevier helped their journal editors to screen articles before their review. These two publishers have in common a large number of copyrighted journals and textbooks but, more importantly, a database of article abstracts. Elsevier is the largest of the five large publishing houses and the only one with a database of article abstracts developed to compete with the bibliometric experts of the Web of Science. The third use and most relevant, Scopus AI, was announced on 16 January 2024, by Elsevier; a version of ChatGPT-3.5 was trained using Elsevier copyrighted material written since 2013. Elsevier's description suggests to the authors that Scopus AI can write review articles or the introductions of original research articles with no human intervention. The editors of non-Elsevier journals not willing to approve the use of Scopus AI for writing scientific articles have a problem on their hands; they will need to trust that the authors who have submitted articles have not lied and have not used Scopus AI at all.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"53 2","pages":"433-442"},"PeriodicalIF":1.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11898249/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Actas espanolas de psiquiatria","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.62641/aep.v53i2.1849","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
The introduction of ChatGPT3 in 2023 disrupted the field of artificial intelligence (AI). ChatGPT uses large language models (LLMs) but has no access to copyrighted material including scientific articles and books. This review is limited by the lack of access to: (1) prior peer-reviewed articles and (2) proprietary information owned by the companies. Despite these limitations, the article reviews the use of LLMs in the publishing of scientific articles. The first use was plagiarism software. The second use by the American Psychological Association and Elsevier helped their journal editors to screen articles before their review. These two publishers have in common a large number of copyrighted journals and textbooks but, more importantly, a database of article abstracts. Elsevier is the largest of the five large publishing houses and the only one with a database of article abstracts developed to compete with the bibliometric experts of the Web of Science. The third use and most relevant, Scopus AI, was announced on 16 January 2024, by Elsevier; a version of ChatGPT-3.5 was trained using Elsevier copyrighted material written since 2013. Elsevier's description suggests to the authors that Scopus AI can write review articles or the introductions of original research articles with no human intervention. The editors of non-Elsevier journals not willing to approve the use of Scopus AI for writing scientific articles have a problem on their hands; they will need to trust that the authors who have submitted articles have not lied and have not used Scopus AI at all.
期刊介绍:
Actas Españolas de Psiquiatría publicará de manera preferente trabajos relacionados con investigación clínica en el
área de la Psiquiatría, la Psicología Clínica y la Salud Mental.